Page last updated: 2024-08-21

fluorobenzenes and Hypertriglyceridemia

fluorobenzenes has been researched along with Hypertriglyceridemia in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calza, L; Falasca, K; Mancino, P; Pizzigallo, E; Ucciferri, C; Vecchiet, J1
Carlson, DM; Gold, A; Jones, PH; Kelly, MT; McKenney, JM; Roth, EM; Setze, CM; Stolzenbach, JC; Williams, LA1
Ballantyne, CM; Jones, PH; Kelly, MT; Lele, A; Setze, CM; Stolzenbach, JC; Thakker, KM1
Abaigar-Luquin, P; Izquierdo-Ortiz, MJ1
Bernal-Rosales, LP; Cervantes, JL; Gonzalez, JG; Marin, JA; Martinez, G; Ocampo, R; Polanco, A; Rodriguez-Briones, I; Sanchez-Mijangos, H; Talavera, JO1
McTaggart, F; Olsson, AG; Raza, A1
Bays, HE; Chitra, RR; Hunninghake, DB; Rader, DJ; Schneck, DW; Simonson, SG; Stein, EA1
Ebihara, Y; Fox, JC; Saito, Y; Sasaki, J; Shirai, K; Yamada, N; Yanase, T1
Gandhi, SK; Ghali, JK; Hassman, DR; Insull, W; Miller, E; Y As, JW1

Reviews

1 review(s) available for fluorobenzenes and Hypertriglyceridemia

ArticleYear
Rosuvastatin: a highly effective new HMG-CoA reductase inhibitor.
    Cardiovascular drug reviews, 2002,Winter, Volume: 20, Issue:4

    Topics: Animals; Cholesterol; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipoproteinemia Type II; Hypertriglyceridemia; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2002

Trials

6 trial(s) available for fluorobenzenes and Hypertriglyceridemia

ArticleYear
Efficacy and safety of rosuvastatin and fenofibric acid combination therapy versus simvastatin monotherapy in patients with hypercholesterolemia and hypertriglyceridemia: a randomized, double-blind study.
    American journal of cardiovascular drugs : drugs, devices, and other interventions, 2010, Volume: 10, Issue:3

    Topics: Adult; Aged; Anticholesteremic Agents; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Female; Fenofibrate; Fluorobenzenes; Humans; Hypercholesterolemia; Hypertriglyceridemia; Liver; Male; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Simvastatin; Sulfonamides

2010
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides.
    Cardiovascular drugs and therapy, 2011, Volume: 25, Issue:1

    Topics: Anticholesteremic Agents; Apolipoproteins B; Atorvastatin; Cholesterol, LDL; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Fenofibrate; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Male; Middle Aged; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Triglycerides

2011
A double-blind, double-dummy, randomized, placebo-controlled trial to evaluate the effect of statin therapy on triglyceride levels in Mexican hypertriglyceridemic patients.
    Current medical research and opinion, 2013, Volume: 29, Issue:4

    Topics: Apolipoprotein A-I; Apolipoproteins B; Cardiovascular Diseases; Cholesterol; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Lipoproteins, HDL; Lipoproteins, LDL; Male; Metabolic Syndrome; Mexico; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides

2013
Rosuvastatin improves the atherogenic and atheroprotective lipid profiles in patients with hypertriglyceridemia.
    Coronary artery disease, 2004, Volume: 15, Issue:2

    Topics: Analysis of Variance; Apolipoproteins; Double-Blind Method; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Lipoproteins; Middle Aged; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome

2004
Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.
    Atherosclerosis, 2007, Volume: 194, Issue:2

    Topics: Apolipoproteins; Bezafibrate; Cholesterol; Dose-Response Relationship, Drug; Double-Blind Method; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Japan; Pyrimidines; Rosuvastatin Calcium; Sulfonamides; Triglycerides

2007
Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial.
    Mayo Clinic proceedings, 2007, Volume: 82, Issue:5

    Topics: Aged; Atorvastatin; Cholesterol, LDL; Coronary Disease; Creatinine; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Male; Managed Care Programs; Middle Aged; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Simvastatin; Sulfonamides

2007

Other Studies

3 other study(ies) available for fluorobenzenes and Hypertriglyceridemia

ArticleYear
Severe HIV-associated hypertriglyceridaemia treated with rosuvastatin plus omega-3 fatty acids.
    International journal of STD & AIDS, 2009, Volume: 20, Issue:8

    Topics: Adult; Drug Therapy, Combination; Fatty Acids, Omega-3; Fluorobenzenes; HIV Infections; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Male; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2009
Severe hypertriglyceridaemia. Treatment with plasmapheresis.
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2012, May-14, Volume: 32, Issue:3

    Topics: Acrylic Resins; Combined Modality Therapy; Fenofibrate; Filtration; Fluorobenzenes; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertriglyceridemia; Hypolipidemic Agents; Male; Middle Aged; Molecular Weight; Plasmapheresis; Practice Guidelines as Topic; Pyrimidines; Rosuvastatin Calcium; Sulfonamides

2012
Rosuvastatin--a new lipid-lowering drug.
    The Medical letter on drugs and therapeutics, 2003, Oct-13, Volume: 45, Issue:1167

    Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hypertriglyceridemia; Hypolipidemic Agents; Pleurodynia, Epidemic; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Sulfonamides

2003